US 2016/0263138 A1Published application

Platform drug delivery system utilizing crystal engineering and theanine dissolution

AssigneeTheaprin Pharmaceuticals Inc.

InventorsHARRY G. BRITTAIN, Philip V. Felice

Life of this patent

Estimating the term…

Abstract

A method of treating Hodgkin's disease in a subject. The method involves administering to the subject an effective amount of a water-soluble composition which includes a cocrystal composition containing doxorubicin and a theanine enantiomer.

Claims23

Dependent claims

A method of treating Hodgkin's disease in a subject by administering to the subject an effective amount of a water-soluble composition comprising:

a cocrystal composition containing a quantity of doxorubicin and a quantity of a theanine enantiomer.

Dependencies are inferred from the claim text.

Facts

Application: 15/097,681Filed 13 Apr 2016
Priority: 9 Mar 2015
Published: 15 Sep 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification83 codes

A61K 9/145
Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried,…: with…
A61K 31/13
Medicinal preparations containing organic active ingredients: amines
A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
A61K 31/192
Carboxylic acids, e.g. valproic acid: having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid

Family

Application14/642,191Division · filed 9 Mar 2015
Application15/097,681Division
US 2016/0263224 A1Published application
US 9,603,937 B2Related patent
US 9,603,939 B2Related patent
US 2016/0263138 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results